Cationic and biocompatible polymer/lipid nanoparticles as immunoadjuvants


Butantan affiliation
External affiliation
Publication type
Article
Language
English
Access rights
Open access
Terms of use
CC BY
Appears in Collections:
Metrics
Abstract
Nanostructures have been of paramount importance for developing immunoadjuvants. They must be cationic and non-cytotoxic, easily assembling with usually oppositely charged antigens such as proteins, haptens or nucleic acids for use in vaccines. We obtained optimal hybrid nanoparticles (NPs) from the biocompatible polymer poly(methyl methacrylate) (PMMA) and the cationic lipid dioctadecyl dimethyl ammonium bromide (DODAB) by emulsion polymerization of methyl methacrylate (MMA) in the presence of DODAB. NPs adsorbed ovalbumin (OVA) as a model antigen and we determined their adjuvant properties. Interestingly, they elicited high double immune responses of the cellular and humoral types overcoming the poor biocompatibility of DODAB-based adjuvants of the bilayer type. The results suggested that the novel adjuvant would be possibly of use in a variety of vaccines.
Reference
Pérez-Betancourt Y, Araujo PM, Távora BCLF, Pereira DR, Faquim Mauro EL, Carmona-Ribeiro AM. Cationic and biocompatible polymer/lipid nanoparticles as immunoadjuvants. Pharmaceutics. 2021 Nov;13(11):1859. doi:10.3390/pharmaceutics13111859.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/3998
Journal title
Issue Date
2021


Files in This Item:

pharmaceutics-13-01859.pdf
Description:
Size: 2.82 MB
Format: Adobe PDF
View/Open
Show full item record

This item is licensed under a Creative Commons License Creative Commons